FDA unveils comprehensive strategy for regulating AI in medical products

FDA unveils comprehensive strategy for regulating AI in medical products

Source: 
Biopharma Reporter
snippet: 

With the pharma and healthcare landscape increasingly being shaped by artificial intelligence (AI), the US Food and Drug Administration (FDA) has taken proactive steps to outline a comprehensive strategy for regulating AI in medical products.